Skip to main content
SpringerLink
Log in

Role of irradiation for patients over 80 years old with glioblastoma: a retrospective cohort study

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

To assess efficacy and safety of hypofractionated radiation therapy (HRT) in patients over 80 years old with newly diagnosed glioblastoma (GBM). Between June 2009 and September 2015, patients in this population with a recommendation for radiation therapy from a multidisciplinary tumor board, and a Karnofsky performance status (KPS) ≥60 as assessed by a radiation oncologist, who received HRT (40 Gy/15 fractions) ± concomitant and adjuvant temozolomide (TMZ) were retrospectively analyzed. A total of 21 patients fulfilled the criteria for eligibility. Median KPS was 80 (60–90). After a median follow-up of 5.8 months (IQR 3.7–13.1 months), median overall survival (OS) was 7.5 months (95 % CI 4.5–19.1) and the 1-year and 2-year OS were 39.5 % (95 % CI 21.9–71.2 %) and 6.6 % (95 % CI 1.0− 43.3 %), respectively. Median progression-free survival (PFS) was 5.8 months (95 % CI 3.9–7.7 months), 1-year and 2-year PFS were 15.2 % (95 % CI 4.4–52.4) and 0 %, respectively. Overall, 16 (76.2 %) patients presented a recurrence. Overall seven patients (33.3 %) needed to be hospitalized during treatment. On univariate analysis, hospitalization was the only variable that correlated with less favourable outcome in terms of both OS (12.2 months versus 3.8 months, p < 0.010) and PFS (5.8 months versus 3.4 months, p = 0.002). Our study suggests that HRT is feasible with acceptable tolerance among “very elderly” patients affected by GBM. Patients 80 and older should be considered for management based on RT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ostrom QT, Gittleman H, Fulop J, Liu M, Blonda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol 17:iv1–iv62

    Article  PubMed  Google Scholar 

  2. Ferguson M, Rodrigues G, Cao J, Bauman G (2014) Management of high-grade gliomas in the elderly. Semin Radiat Oncol 24:279–288

    Article  PubMed  Google Scholar 

  3. Paszat L, Laperriere N, Groome P, Schulze K, Mackillop W, Holowaty E (2001) A population-based study of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 51:100–107

    Article  CAS  PubMed  Google Scholar 

  4. Barnholtz-Sloan JS, Williams VL, Maldonado JL, Shahani D, Stockwell HG, Chamberlain M, Sloan AE (2008) Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 108:642–648

    Article  PubMed  Google Scholar 

  5. Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE (2008) Patterns of care in elderly glioblastoma patients. Ann Neurol 64:628–634

    Article  PubMed  Google Scholar 

  6. Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, Eisenhauer E, Belanger K, Brandes AA, Allgeier A, Lacombe D, Stupp R (2008) Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981–22981/CE.3. Lancet Oncol 9:29–38

    Article  PubMed  Google Scholar 

  7. Stupp R, Hegi ME, Mason WP, Van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups, National Cancer Institute of Canada Clinical Trials Group (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466

    Article  CAS  PubMed  Google Scholar 

  8. Li J, Wang M, Won M, Shaw EG, Coughlin C, Curran WJ Jr, Mehta MP (2011) Validation and simplification of the radiation therapy oncology group recursive partitioning analysis classification for glioblastoma. Int J Radiat Oncol Biol Phys 81:623–630

    Article  PubMed  Google Scholar 

  9. Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, FrenayM, Kantor G, Guillamo JS, Jadaud E, Colin P, Bondiau PY, Meneï P, Loiseau H, Bernier V, Honnorat J, Barrié M, Mokhtari K, Mazeron JJ, Bissery A, Delattre JY, Association of French-Speaking Neuro-Oncologists (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527–1535

    Article  CAS  PubMed  Google Scholar 

  10. Roa W, Brasher PM, Bauman G, Anthes M, Bruera E, Chan A, Fisher B, Fulton D, Gulavita S, Hao C, Husain S, Murtha A, Petruk K, Stewart D, Tai P, Urtasun R, Cairncross JG, Forsyth P (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1583–1588

    Article  CAS  PubMed  Google Scholar 

  11. Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G, Weller M (2012) NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13:707–715

    Article  CAS  PubMed  Google Scholar 

  12. Malmström A, Grønberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, Abacioglu U, Tavelin B, Lhermitte B, Hegi ME, Rosell J, Henriksson R, Nordic Clinical Brain Tumour Study Group (NCBTSG) (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 13:916–926

    Article  PubMed  Google Scholar 

  13. Laperriere N, Weller M, Stupp R, Perry JR, Brandes AA, Wick W, van den Bent MJ (2013) Optimal management of elderly patients with glioblastoma. Cancer Treat Rev 39:350–357

    Article  PubMed  Google Scholar 

  14. Perry JR, O’Callaghan CJ, Ding K, Roa W, Mason WP, Cairncross JG, Brandes AA, Menten J, Phillips C, Fay MF, Nishikawa R, Winch C, Laperriere N (2014) A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (NCIC CTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677). Neuro Oncol 16 (suppl 3):iii46

    Article  Google Scholar 

  15. Brandes AA, Vastola F, Basso U, Berti F, Pinna G, Rotilio A, Gardiman M, Scienza R, Monfardini S, Ermani M (2003) A prospective study on glioblastoma in the elderly. Cancer 97:657–662

    Article  PubMed  Google Scholar 

  16. Wen PY, MacDonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972

    Article  PubMed  Google Scholar 

  17. Idbaih A, Taillibert S, Simon JM, Psimaras D, Schneble HM, Lopez S, Lang P, Toubiana T, Feuvret L, Delattre JY, Mazeron JJ (2008) Short course of radiation therapy in elderly patients with glioblastoma multiforme. Cancer Radiother 12:788–792

    Article  CAS  PubMed  Google Scholar 

  18. Piccirilli M, Bistazzoni S, Gagliardi FM, Landi A, Santoro A, Giangaspero F, Salvati M (2006) Treatment of glioblastoma multiforme in elderly patients. Clinico-therapeutic remarks in 22 patients olderthan 80 years. Tumori 92:98–103

    PubMed  Google Scholar 

  19. Uzuka T, Asano K, Sasajima T, Sakurada K, Kumabe T, Beppu T, Ichikawa M, Kitanaka C, Aoki H, Saito K, Ogasawara K, Tominaga T, Mizoi K, Ohkuma H, Fujii Y, Kayama T, Tohoku Brain Tumor Study Group (2014) Treatment outcomes in glioblastoma patients aged 76 years or older: a multicenter retrospective cohort study. J Neurooncol 116:299–306

    Article  PubMed  Google Scholar 

  20. Pérez-Larraya JG, Ducray F, Chinot O, Catry-Thomas I, Taillandier L, Guillamo JS, Campello C, Monjour A, Cartalat-Carel S, Barrie M, Huchet A, Beauchesne P, Matta M, Mokhtari K, Tanguy ML, Honnorat J, Delattre JY (2011) Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. J Clin Oncol 29:3050–3055

    Article  Google Scholar 

  21. Minniti G, Lanzetta G, Scaringi C, Caporello P, Salvati M, Arcella A, De Sanctis V, Giangaspero F, Enrici RM (2012) Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys 83:93–99

    Article  CAS  PubMed  Google Scholar 

  22. Hegi ME, Diserens AC, Gorlia T, Hamou MF, De Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JEC, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003

    Article  CAS  PubMed  Google Scholar 

  23. Weller M1, Stupp R, Reifenberger G, Brandes AA, van den Bent MJ, Wick W, Hegi ME (2010) MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat Rev Neurol 6:39–51

    Article  CAS  PubMed  Google Scholar 

  24. Minniti G, Scaringi C, Lanzetta G, Terrenato I, Esposito V, Arcella A, Pace A, Giangaspero F, Bozzao A, Enrici RM (2015) standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis. Int J Radiat Oncol Biol Phys 91:109–115

    Article  CAS  Google Scholar 

  25. Arvold ND, Wang Y, Zigler C, Schrag D, Dominici F (2014) Hospitalization burden and survival among older glioblastoma patients. Neuro Oncol 16:1530–1540

    Article  PubMed  PubMed Central  Google Scholar 

  26. Soussain C, Ricard D, Fike JR, Mazeron JJ, Psimaras D, Delattre JY (2009) CNS complications of radiotherapy and chemotherapy. Lancet 374:1639–1651

    Article  CAS  PubMed  Google Scholar 

  27. Wang TJ, Wu CC, Jani A, Estrada J, Ung T, Chow DS, Soun JE, Saad S, Qureshi YH, Gartrell R, Saadatmand HJ, Saraf A, Garrett MD, Grubb C, Isaacson SR, Cheng SK, Sisti MB, Bruce JN, Sheth SA, Lassman AB, Iwamoto FM, McKhann GM (2015) Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with newly diagnosed glioblastoma. Pract Radiat Oncol. doi:10.1016/j.prro.2015.12.001

  28. Roa W, Kepka L, Kumar N, Sinaika V, Matiello J, Lomidze D, Hentati D, Guedes de Castro D, Dyttus-Cebulok K, Drodge S, Ghosh S, Jeremić B, Rosenblatt E, Fidarova E (2015) International atomic energy agency randomized phase III study of radiation therapy in elderly and/or frail patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 33:4145–4150

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Sapienza University, Sant’Andrea Hospital, Via di Grottarossa 1035-1039, 00189, Rome, Italy

    Stefano Bracci

  2. Department of Neurology Mazarin, groupe hospitalier La Pitié Salpêtrière-Charles Foix (Assistance Publique-Hôpitaux de Paris), 47-83 Boulevard de l’hôpital, 75651, Paris cedex 13, France

    Florence Laigle-Donadey, Alberto Duran-Peña, Jean-Yves Delattre & Khê Hoang-Xuan

  3. Department of Radiation Oncology, University of Florida, 2000 SW Archer Road, Gainesville, Fl, 32610, USA

    Kathryn Hitchcock

  4. Department of Neurosurgery, groupe hospitalier La Pitié Salpêtrière-Charles Foix (Assistance Publique-Hôpitaux de Paris), 47-83 Boulevard de l’hôpital, 75651, Paris cedex 13, France

    Soledad Navarro

  5. Department of Radiation Oncology, groupe hospitalier La Pitié Salpêtrière-Charles Foix (Assistance Publique-Hôpitaux de Paris), 47-83 Boulevard de l’hôpital, 75651, Paris cedex 13, France

    Antoine Chevalier, Julian Jacob, Idriss Troussier, Jean-Jacques Mazeron & Loïc Feuvret

Authors
  1. Stefano Bracci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Florence Laigle-Donadey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kathryn Hitchcock
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alberto Duran-Peña
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Soledad Navarro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Antoine Chevalier
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Julian Jacob
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Idriss Troussier
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jean-Yves Delattre
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jean-Jacques Mazeron
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Khê Hoang-Xuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Loïc Feuvret
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefano Bracci.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bracci, S., Laigle-Donadey, F., Hitchcock, K. et al. Role of irradiation for patients over 80 years old with glioblastoma: a retrospective cohort study. J Neurooncol 129, 347–353 (2016). https://doi.org/10.1007/s11060-016-2182-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-016-2182-1

Keywords

Search

Navigation